Unknown

Dataset Information

0

A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.


ABSTRACT: Matrix metalloproteinase-14 (MMP-14) is a clinically relevant target in metastatic cancers due to its role in tumor progression and metastasis. Since active MMP-14 is localized on the cell surface, it is amenable to antibody-mediated blockade in cancer, and here we describe our efforts to develop novel inhibitory anti-MMP-14 antibodies. A phage-displayed synthetic humanized Fab library was screened against the extracellular domain of MMP-14 and a panel of MMP14-specific Fabs were identified. A lead antibody that inhibits the catalytic domain of MMP-14 (Fab 3369) was identified and treatment of MDA-MB-231 breast cancer cells with Fab 3369 led to significant loss of extracellular matrix degradation and cell invasion abilities. In mammary orthotopic tumor xenograft assays, MMP-14 blockade by IgG 3369 limited tumor growth and metastasis. Analysis of tumor tissue sections revealed that MMP-14 blockade limited tumor neoangiogenesis and hypoxia. Similar effects of MMP-14 blockade in syngeneic 4T1 mammary tumors were observed, along with increased detection of cytotoxic immune cell markers. In conclusion, we show that immunotherapies targeting MMP-14 can limit immune suppression, tumor progression, and metastasis in triple-negative breast cancer.

SUBMITTER: Ling B 

PROVIDER: S-EPMC5601659 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.

Ling Binbing B   Watt Kathleen K   Banerjee Sunandan S   Newsted Daniel D   Truesdell Peter P   Adams Jarrett J   Sidhu Sachdev S SS   Craig Andrew W B AWB  

Oncotarget 20170509 35


Matrix metalloproteinase-14 (MMP-14) is a clinically relevant target in metastatic cancers due to its role in tumor progression and metastasis. Since active MMP-14 is localized on the cell surface, it is amenable to antibody-mediated blockade in cancer, and here we describe our efforts to develop novel inhibitory anti-MMP-14 antibodies. A phage-displayed synthetic humanized Fab library was screened against the extracellular domain of MMP-14 and a panel of MMP14-specific Fabs were identified. A l  ...[more]

Similar Datasets

2023-01-23 | GSE220683 | GEO
2019-11-13 | GSE136206 | GEO
| S-EPMC5318978 | biostudies-literature
| S-EPMC8705248 | biostudies-literature
| S-EPMC8401402 | biostudies-literature
| S-EPMC4102808 | biostudies-other
| S-EPMC5901982 | biostudies-literature
| S-EPMC7565743 | biostudies-literature
| S-EPMC4058041 | biostudies-literature
| S-EPMC8801574 | biostudies-literature